Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
431 participants
INTERVENTIONAL
2017-12-01
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reducing UV Exposure to Prevent Skin Cancer: Message Development & Testing
NCT03201120
SunSmart Intervention in Schools
NCT03745872
Health Promotion and Fitness for Younger and Older Adults With SMI
NCT02090335
Social Media Indoor Tanning Study
NCT03834974
A Randomized Control Trial of Sun Protection Interventions for Operating Engineers
NCT01804595
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study evaluates the impact of the AAD SPOTme® skin cancer screening events on attendees' skin cancer prevention and detection behaviors. This study will also evaluate whether an educational intervention will improve post-screening engagement of attendees with dermatologists.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention Arm 1
Individuals randomized to intervention group 1 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 AND will receive additional skin cancer screening educational materials.
Intervention Arm
Individuals randomized to the intervention group will receive skin cancer screening educational materials.
AAD SPOTmeⓇ skin cancer screening
All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.
Intervention Arm 2
Individuals randomized to intervention group 2 will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017 only.
AAD SPOTmeⓇ skin cancer screening
All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention Arm
Individuals randomized to the intervention group will receive skin cancer screening educational materials.
AAD SPOTmeⓇ skin cancer screening
All study participants will have participated in the AAD SPOTmeⓇ skin cancer screening program in either 2016 or 2017.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have a presumptive diagnosis (screening, non-confirmed) of melanoma
* Have provided the AAD with permission to be re-contacted
* Have provided the AAD with an email address
* Aged 18 years or older
* Able to read English
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
American Academy of Dermatology (AAD)
UNKNOWN
Harvard School of Public Health (HSPH)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alan Geller
MPH, RN
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alan Geller, MPH, RN
Role: PRINCIPAL_INVESTIGATOR
Harvard TH Chan School of Public Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Harvard TH Chan School of Public Health
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-1668
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.